Literature DB >> 25747394

Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: benefits of atrial natriuretic peptide, losartan, and tempol.

S L Della Penna1, M I Rosón, J E Toblli, B E Fernández.   

Abstract

The body regulates plasma sodium levels within a small physiologic range, despite large variations in daily sodium and water intake. It is known that sodium transport in the kidneys plays an important role in hypoxia, being the major determinant of renal oxygen consumption. Tubular epithelial cell hypoxia is an important contributor to the development of renal inflammation, and the damage may progress to structural injury, ending in acute renal failure. In this review, we will summarize the renal inflammatory effects of high acute plasma sodium (acute hypernatremia), and the molecular mechanisms involved. We will also discuss recent findings related to the role of oxidative stress and angiotensin II (Ang II) in the pathogenesis of renal injury. We will comment on the effects of agents used to prevent or attenuate the inflammatory response, such as the atrial natriuretic peptide, the superoxide dismutase mimetic - tempol, and losartan.

Entities:  

Keywords:  hypernatremia; inflammation; losartan; oxidative stress; tempol

Mesh:

Substances:

Year:  2015        PMID: 25747394     DOI: 10.3109/10715762.2015.1006216

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  6 in total

1.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Clues and new evidences in arterial hypertension: unmasking the role of the chloride anion.

Authors:  Nicolás Martín Kouyoumdzian; Gabriel Kim; María Julieta Rudi; Natalia Lucía Rukavina Mikusic; Belisario Enrique Fernández; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2021-12-30       Impact factor: 3.657

3.  Associations of Dysnatremia with COVID-19 Status and Mortality.

Authors:  Diane Liu; Wenzhu Mowrey; Molly Fisher; Abby Basalely; John McCarthy; Neelja Kumar; Jyotsana Thakkar; Yorg Azzi; Maureen Brogan; Ladan Golestaneh; Kimberly J Reidy; Wei Chen
Journal:  Kidney360       Date:  2022-06-03

4.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

5.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09

6.  Angiotensin II Stimulates the NLRP3 Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction.

Authors:  Min Zhao; Mi Bai; Guixia Ding; Yue Zhang; Songming Huang; Zhanjun Jia; Aihua Zhang
Journal:  Kidney Dis (Basel)       Date:  2018-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.